Patients with estrogen receptor-positive (ER+) breast cancer, the most common type, are at risk for disease recurrence in other parts of the body for years after diagnosis and treatment of the primary tumor.

Now, researchers from the Cancer Research Institute (ICR), in the United Kingdom, claim to have unraveled the mechanism that leads breast cancer cells to wake up years after a successful treatment, leading to metastasis in the lung.

The discovery was published on Monday (13/3), in the journal Nature Cancer, and marks an important step in studies to combat cancer. Carried out in mice, the work reveals how this relapse occurs and points out a strategy to avoid it.

specific protein

The researchers found that the protein PDGF-C, present in the lung, plays a key role in influencing whether dormant breast cancer cells stay asleep or wake up.

When the level of PDGF-C increases – which is more likely in the elderly or when organ tissue is worn down or scarred – the chances of latent cancer cells growing into secondary breast cancer are not increased.

Advertising by Metrópoles 1 partner
Advertising by Metrópoles 2 partner
Advertising by Metrópoles 3 partner
Advertising by Metrópoles 4 partner
Advertising by Metrópoles 5 partner
Advertising by Metrópoles 6 partner
Advertising by Metrópoles 7 partner

0

Treatment

After unraveling the mechanism, the researchers sought a strategy to block the increase in the PDGF-C protein. Tests with mice with ER+ tumors showed that the use of imatinib, before and after tumor development, significantly reduced secondary cancer growth. The drug is currently used to treat patients with chronic myelogenous leukemia,

“We discovered how aging lung tissue can cause cancer cells to ‘wake up’ and transform into tumors, and we found a potential strategy to ‘defuse’ these ‘time bombs,'” says Frances Turrell, one of the study’s authors. , in a statement released by the English institution.

Now, the team plans to continue with research to understand how human patients can benefit from the use of imatinib. In the long term, they intend to develop specific treatments.

Get news from metropolises on your Telegram and stay on top of everything! Just access the channel: https://t.me/metropolesurgente.

California18

Welcome to California18, your number one source for Breaking News from the World. We’re dedicated to giving you the very best of News.

Leave a Reply